TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Ind-Swift Laboratories Ltd. ( (IN:INDSWFTLAB) ) is now available.
Ind-Swift Laboratories Ltd. has announced the scheduling of its 30th Annual General Meeting (AGM) on September 29, 2025, which will be conducted via video conferencing in compliance with regulatory guidelines. The company has also made its Annual Report for the financial year 2024-25 available online, ensuring transparency and accessibility for stakeholders. This move highlights Ind-Swift’s commitment to maintaining open communication with its shareholders and adhering to regulatory requirements, potentially strengthening its position in the market.
More about Ind-Swift Laboratories Ltd.
Ind-Swift Laboratories Ltd. operates in the pharmaceutical industry, focusing on the development and manufacturing of active pharmaceutical ingredients and intermediates. The company is known for its commitment to quality and innovation, serving a global market with a diverse range of pharmaceutical products.
Average Trading Volume: 18,511
Technical Sentiment Signal: Buy
Current Market Cap: 6.18B INR
For a thorough assessment of INDSWFTLAB stock, go to TipRanks’ Stock Analysis page.